Q4 Earnings Roundup EID Parry Posts Loss Marksans Pharma and Astra Microwave See Profit Growth AIA Engineering Reports Decline Ferrari Lear Intuitive Machines Micron Lead Premarket Movers Prediction Market Suggests SpaceX OpenAI Could Surpass 14 Trillion Valuations on Debut Spire Global Selected by Amadeus IT Group to Supply Aircraft Tracking Data Pokmon Card Market Surges Amid Nostalgia Speculation and HighProfile Collectors China Calls for APEC Economic Cooperation as Commerce Minister Skips Meeting Over Urgent Official Business SKIN Q1 2026 Earnings EPS Beats Estimates Amid NarrowerThanExpected Loss Ivanhoe Electric Inc Q1 2026 Earnings Deep EPS Miss Amidst PreRevenue Exploration Phase CNH Q1 2026 Earnings EPS Surprises 754 Above Estimate Amid Challenging Environment TAC Q1 2026 Earnings EPS Falls Short of Estimates Stock Still Up 152 ULCC Q1 2026 Earnings Narrowerthanexpected loss as cost discipline aids results COPEL Q2 2025 Earnings Strong EPS Beat of 5848 Despite Marginal Stock Decline Riskified Ltd RSKD Slides 242 as Shares Approach Key Support Level Republic Airways Slides 218 Approaches Key Support as Regional Airline Sector Weakens Tivic Health Systems TIVC Holds Steady at 140 as Key Support and Resistance Levels Define Range HEQ Holds Steady at 1166 as Income Fund Consolidates Within Established Range NewHold Investment Corp III NHIC Holds Steady at 1057 as SPAC Market Waits AmeriVet Securities Greg Faranello Examines Recent Treasury Yield Dynamics HWM Q1 2026 Earnings Strong EPS Beat Signals Operational Efficiency Amid Aerospace Demand Stoke Therapeutics STOK Edges Lower Mixed Signals Near Key Resistance ZION Q1 2026 Earnings EPS Surpasses Estimates by Over 7 Amid Solid Operating Performance SAM Q1 2026 Earnings EPS Misses Estimates by 175 Stock Edges Higher HCAT Q1 2026 Earnings Earnings Per Share Surpasses Estimates Stock Rises 77 NAGE Q1 2026 Earnings Modest EPS Beat Amid Limited Revenue Disclosure Bunge Limited Q1 2026 Earnings Massive EPS Beat Drives Modest Stock Uptick 374Water Inc SCWO Q1 2026 Earnings Narrowing Losses and Commercial Progress Highlight a Quarter of Transition CLDX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline